RAS(ON) Therapies on the Horizon to Address KRAS Resistance: Highlight on a Phase III Clinical Candidate Daraxonrasib (RMC-6236)

已完结 10 由龙行天下发布于 2026/8/24 12:36:08

DOI:10.1021/acs.jmedchem.5c01441
作者：Zonghui Ma,?Mingxiang Zhou,?Qiang Shen and Jia Zhou*,?
文献类型：期刊论文
补充材料：只需要正文

American Chemical Society (ACS)

应助信息

1天前

yduan

55eb7fec9f7611f1bd7334735aa3bc31.pdf 已采纳

1天前

Book学术机器人

2026/8/24 12:36:08 未找到该文献，机器人已退出，请等待人工下载

2026/8/24 12:36:08 Book学术AI机器人收到请求，开始寻找文献

2026/8/24 12:36:08 已向机器人发送请求

1天前

龙行天下发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:International Society for Optics and Photonics (SPIE)Low temperature bonding of heterogeneous materials using Al2O3 as an intermediate layer